Conclusions: The use of ARNI for the patients with acute HF (EF ≤ 40%) ted to a reduction of NT-ProBNP, LVED and increasing EF (p<0.01). Rates of worsening renal function hyperkalemia, symptomatic hypotension and angioderma were not serious.